335 related articles for article (PubMed ID: 2102801)
1. Species differences in susceptibility to ischemic injury and responsiveness to myocardial protection.
Galiñanes M; Hearse DJ
Cardioscience; 1990 Jun; 1(2):127-43. PubMed ID: 2102801
[TBL] [Abstract][Full Text] [Related]
2. Transient hypocalcemic reperfusion does not improve postischemic recovery in the rat heart after preservation with St. Thomas' Hospital cardioplegic solution.
Chambers DJ; Harvey DM; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1992 Aug; 104(2):344-56. PubMed ID: 1495296
[TBL] [Abstract][Full Text] [Related]
3. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
[TBL] [Abstract][Full Text] [Related]
4. Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium.
Baker JE; Boerboom LE; Olinger GN
J Thorac Cardiovasc Surg; 1988 Nov; 96(5):717-24. PubMed ID: 3184966
[TBL] [Abstract][Full Text] [Related]
5. Long-term preservation of the heart: the effect of infusion pressure during continuous hypothermic cardioplegia.
Chambers DJ; Takahashi A; Hearse DJ
J Heart Lung Transplant; 1992; 11(4 Pt 1):665-75. PubMed ID: 1498129
[TBL] [Abstract][Full Text] [Related]
6. Protection of the chronic hypoxic immature rat heart during global ischemia.
Karck M; Ziemer G; Zoeller M; Schulte S; Juergens KD; Weisser H; Haverich A
Ann Thorac Surg; 1995 Mar; 59(3):699-706. PubMed ID: 7887715
[TBL] [Abstract][Full Text] [Related]
7. Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart.
Kempsford RD; Hearse DJ
J Thorac Cardiovasc Surg; 1989 Jun; 97(6):856-63. PubMed ID: 2498580
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ischemic vulnerability and responsiveness to cardioplegic protection in crystalloid-perfused versus blood-perfused hearts.
Qiu Y; Hearse DJ
J Thorac Cardiovasc Surg; 1992 May; 103(5):960-8. PubMed ID: 1569777
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
[TBL] [Abstract][Full Text] [Related]
10. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution.
Yang SS; Hearse DJ
Can J Cardiol; 1989; 5(8):401-7. PubMed ID: 2514036
[TBL] [Abstract][Full Text] [Related]
11. The immature and the mature myocardium. Responses to multidose crystalloid cardioplegia.
Magovern JA; Pae WE; Miller CA; Waldhausen JA
J Thorac Cardiovasc Surg; 1988 Apr; 95(4):618-24. PubMed ID: 3352295
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of crystalloid cardioplegic protection against global normothermic ischemia by superoxide dismutase plus catalase but not diltiazem in the isolated, working rat heart.
Greenfield DT; Greenfield LJ; Hess ML
J Thorac Cardiovasc Surg; 1988 May; 95(5):799-813. PubMed ID: 3361928
[TBL] [Abstract][Full Text] [Related]
13. Exogenous adenosine accelerates recovery of cardiac function and improves coronary flow after long-term hypothermic storage and transplantation.
Galiñanes M; Hearse DJ
J Thorac Cardiovasc Surg; 1992 Jul; 104(1):151-8. PubMed ID: 1614201
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of diltiazem and ryanodine against ischemia-reperfusion injury in neonatal rabbit hearts.
Akita T; Abe T; Kato S; Kodama I; Toyama J
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):55-66. PubMed ID: 8321005
[TBL] [Abstract][Full Text] [Related]
15. Optimal myocardial protection during crystalloid cardioplegia. Interrelationship between volume and duration of infusion.
Takahashi A; Chambers DJ; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1988 Nov; 96(5):730-40. PubMed ID: 3184967
[TBL] [Abstract][Full Text] [Related]
16. Is protection of ischemic neonatal myocardium by cardioplegia species dependent?
Baker JE; Boerboom LE; Olinger GN
J Thorac Cardiovasc Surg; 1990 Feb; 99(2):280-7. PubMed ID: 2299865
[TBL] [Abstract][Full Text] [Related]
17. Assessment of ischemic injury and protective interventions: the Langendorff versus the working rat heart preparation.
Galinanes M; Hearse DJ
Can J Cardiol; 1990 Mar; 6(2):83-91. PubMed ID: 2310998
[TBL] [Abstract][Full Text] [Related]
18. Detrimental effects of temperature on the efficacy of the University of Wisconsin solution when used for cardioplegia at moderate hypothermia. Comparison with the St. Thomas Hospital solution at 4 degrees C and 20 degrees C.
Amrani M; Ledingham S; Jayakumar J; Allen NJ; Rothery S; Severs N; Yacoub M
Circulation; 1992 Nov; 86(5 Suppl):II280-8. PubMed ID: 1424014
[TBL] [Abstract][Full Text] [Related]
19. [Effects of ischemic preconditioning on the recovery of myocardial function after unprotected ischemia and cardioplegia in the isolated and crystalloid perfused rat hearts].
Otani H; Kawasaki H; Ninomiya H; Kido M; Kawaguchi H; Osako M; Kato Y; Imamura H
Nihon Kyobu Geka Gakkai Zasshi; 1997 Jan; 45(1):23-30. PubMed ID: 9028119
[TBL] [Abstract][Full Text] [Related]
20. St. Thomas' Hospital cardioplegic solution. Beneficial effect of glucose and multidose reinfusions of cardioplegic solution.
von Oppell UO; Du Toit EF; King LM; Owen P; Dunne T; Reichart B; Opie LH
J Thorac Cardiovasc Surg; 1991 Sep; 102(3):405-12. PubMed ID: 1881179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
